Article Information
History
- February 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joseph A. Lewnard1,2,3,*,
- Vennis Hong4,
- Katia J. Bruxvoort5,
- Lindsay R. Grant6,
- Luis Jódar6,
- Alejandro Cané6,
- Adriano Arguedas6,
- Magdalena E. Pomichowski4,
- Bradford D. Gessner6 and
- Sara Y. Tartof4,7,†
- 1Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States
- 2Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States
- 3Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, California 94720, United States
- 4Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101
- 5Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States
- 6Pfizer Vaccines, Collegeville, Pennsylvania 19426, United States
- 7Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California 91101, United States
- ↵*Corresponding author: Joseph Lewnard, 2121 Berkeley Way, Room 5410, Berkeley, California 94720, Email: jLewnard{at}berkeley.edu, Tel.: 510-664-4050
- ↵†Alternate author for correspondence: Sara Tartof, 100 South Los Robles, 2nd floor, Pasadena, California 91101, Email: Sara.Y.Tartof{at}kp.org, Tel.: 626-564-3001
Posted February 24, 2023.
Burden of lower respiratory tract infections preventable by adult immunization with 15- and 20-valent pneumococcal conjugate vaccines in the United States
